A Novel Approach for Predicting Disease-lncRNA Associations Based on the Distance Correlation Set and Information of the miRNAs

Recently, accumulating laboratorial studies have indicated that plenty of long noncoding RNAs (lncRNAs) play important roles in various biological processes and are associated with many complex human diseases. Therefore, developing powerful computational models to predict correlation between lncRNAs and diseases based on heterogeneous biological datasets will be important. However, there are few approaches to calculating and analyzing lncRNA-disease associations on the basis of information about miRNAs. In this article, a new computational method based on distance correlation set is developed to predict lncRNA-disease associations (DCSLDA). Comparing with existing state-of-the-art methods, we found that the major novelty of DCSLDA lies in the introduction of lncRNA-miRNA-disease network and distance correlation set; thus DCSLDA can be applied to predict potential lncRNA-disease associations without requiring any known disease-lncRNA associations. Simulation results show that DCSLDA can significantly improve previous existing models with reliable AUC of 0.8517 in the leave-one-out cross-validation. Furthermore, while implementing DCSLDA to prioritize candidate lncRNAs for three important cancers, in the first 0.5% of forecast results, 17 predicted associations are verified by other independent studies and biological experimental studies. Hence, it is anticipated that DCSLDA could be a great addition to the biomedical research field.

[1]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[2]  F. Hou,et al.  Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex , 2014, British Journal of Cancer.

[3]  S. Dimmeler,et al.  Long Noncoding RNAs in Cardiovascular Diseases , 2015, Circulation research.

[4]  Chuanfang Wu,et al.  17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. , 2014, Biochemical and biophysical research communications.

[5]  Jing Bai,et al.  Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features. , 2015, Molecular bioSystems.

[6]  P. Davis,et al.  Inducible COX-2-dependent apoptosis in human ovarian cancer cells. , 2011, Carcinogenesis.

[7]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[8]  Wei Kong,et al.  A bioinformatics method for predicting long noncoding RNAs associated with vascular disease , 2014, Science China Life Sciences.

[9]  Dapeng Hao,et al.  Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. , 2015, Molecular bioSystems.

[10]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[11]  Jin Meng,et al.  A four-long non-coding RNA signature in predicting breast cancer survival , 2014, Journal of experimental & clinical cancer research : CR.

[12]  W. Lau,et al.  LncRNAs: the bridge linking RNA and colorectal cancer , 2016, Oncotarget.

[13]  Lin Liu,et al.  Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. , 2014, Molecular bioSystems.

[14]  Hui Xiao,et al.  NONCODE v3.0: integrative annotation of long noncoding RNAs , 2011, Nucleic Acids Res..

[15]  D. Chung,et al.  The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. , 2000, Gastroenterology.

[16]  E. Birney,et al.  Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs , 2002, Nature.

[17]  Xing Chen,et al.  Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA , 2015, Scientific Reports.

[18]  S. Brenner,et al.  General Nature of the Genetic Code for Proteins , 1961, Nature.

[19]  R. Salgia,et al.  A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. , 2014, Advances in experimental medicine and biology.

[20]  Yuh-Shan Jou,et al.  Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression , 2016, Oncotarget.

[21]  Randeep Rakwal,et al.  MALAT‐1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility‐related genes , 2010, FEBS letters.

[22]  Q. Cui,et al.  LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations , 2016, Nucleic acids research.

[23]  Jing Fang,et al.  Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression. , 2016, Biochemical and biophysical research communications.

[24]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[25]  F Buffa,et al.  Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival , 2014, Oncogene.

[26]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[27]  Yong Yang,et al.  The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell , 2013, PloS one.

[28]  Haitao Zhao,et al.  Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma , 2014, BioMed research international.

[29]  Mitsuo Oshimura,et al.  Loss of Imprinting of Long QT Intronic Transcript 1 in Colorectal Cancer , 2001, Oncology.

[30]  Brian McCue,et al.  miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer , 2012, Molecular Cancer.

[31]  John S. Mattick,et al.  lncRNAdb: a reference database for long noncoding RNAs , 2010, Nucleic Acids Res..

[32]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[33]  Tim R. Mercer,et al.  NRED: a database of long noncoding RNA expression , 2008, Nucleic Acids Res..

[34]  Limei Ma,et al.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion , 2014, Tumor Biology.

[35]  F. Costa,et al.  Non-coding RNAs: new players in eukaryotic biology. , 2005, Gene.

[36]  Martin Werner,et al.  Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas , 2007, Journal of Molecular Medicine.

[37]  Nan Xu,et al.  Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  A. Giuliano,et al.  Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies , 2016, CA: a cancer journal for clinicians.

[39]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[40]  Hong-Hao Zhou,et al.  Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response , 2016, Tumor Biology.

[41]  Mary Kay Barton,et al.  Local consolidative therapy may be beneficial in patients with oligometastatic non‐small cell lung cancer , 2017, CA: a cancer journal for clinicians.

[42]  M. Guo,et al.  Epigenetic changes in colorectal cancer , 2013, Chinese journal of cancer.